These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15195927)

  • 1. Gene therapy for cardiovascular disease: the potential of VEGF.
    Tiong A; Freedman SB
    Curr Opin Mol Ther; 2004 Apr; 6(2):151-9. PubMed ID: 15195927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic neovascularization for ischemic heart disease.
    Lekas M; Kutryk MJ; Latter DA; Stewart DJ
    Can J Cardiol; 2004 Aug; 20 Suppl B():49B-57B. PubMed ID: 15309206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of cardiovascular disease.
    Nikol S
    Curr Opin Mol Ther; 2008 Oct; 10(5):479-92. PubMed ID: 18830924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on angiogenic gene therapy: vascular endothelial growth factor and other directions.
    Ylä-Herttuala S
    Curr Opin Mol Ther; 2006 Aug; 8(4):295-300. PubMed ID: 16955692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
    Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH
    Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.
    Shah PB; Losordo DW
    Adv Genet; 2005; 54():339-61. PubMed ID: 16096018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current insights on the biology and clinical aspects of VEGF regulation.
    Birk DM; Barbato J; Mureebe L; Chaer RA
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does gene therapy become pharmacotherapy?
    Morishita R; Aoki M; Ogihara T
    Exp Physiol; 2005 May; 90(3):307-13. PubMed ID: 15778409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.
    Ylä-Herttuala S; Markkanen JE; Rissanen TT
    Trends Cardiovasc Med; 2004 Nov; 14(8):295-300. PubMed ID: 15596105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury.
    Hutter R; Carrick FE; Valdiviezo C; Wolinsky C; Rudge JS; Wiegand SJ; Fuster V; Badimon JJ; Sauter BV
    Circulation; 2004 Oct; 110(16):2430-5. PubMed ID: 15477421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vascular endothelial growth factor in restenosis: the controversy continues.
    Shiojima I; Walsh K
    Circulation; 2004 Oct; 110(16):2283-6. PubMed ID: 15492329
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.
    Thébaud B; Ladha F; Michelakis ED; Sawicka M; Thurston G; Eaton F; Hashimoto K; Harry G; Haromy A; Korbutt G; Archer SL
    Circulation; 2005 Oct; 112(16):2477-86. PubMed ID: 16230500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial recovery: the next target in restenosis prevention.
    Losordo DW; Isner JM; Diaz-Sandoval LJ
    Circulation; 2003 Jun; 107(21):2635-7. PubMed ID: 12782613
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene therapy and angiogenesis in patients with coronary artery disease.
    Kastrup J
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1127-38. PubMed ID: 20670190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factors in cardiovascular medicine.
    Testa U; Pannitteri G; Condorelli GL
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1190-221. PubMed ID: 19001927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetech enlightens other angiogenesis programs.
    Brower V
    Nat Biotechnol; 1999 Apr; 17(4):326-7. PubMed ID: 10207873
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic gene regulation: targeting transcription.
    Giordano FJ
    Circulation; 2007 Mar; 115(10):1180-3. PubMed ID: 17353455
    [No Abstract]   [Full Text] [Related]  

  • 20. Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease.
    Mac Gabhann F; Ji JW; Popel AS
    Ann Biomed Eng; 2007 Jun; 35(6):982-94. PubMed ID: 17436110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.